Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPR | P35270 | 1/20 | 0.63 |
| ▸ | ALK | Q9UM73 | 12/20 | 0.57 |
| ▸ | MAP3K7 | O43318 | 3/20 | 0.56 |
| ▸ | IRAK4 | Q9NWZ3 | 3/20 | 0.56 |
| ▸ | IRAK1 | P51617 | 2/20 | 0.56 |
| ▸ | MET | P08581 | 1/20 | 0.54 |
| ▸ | IDH2 | P48735 | 2/20 | 0.49 |
| ▸ | EGFR | P00533 | 2/20 | 0.48 |
| ▸ | KDR | P35968 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL572281 | 0.88 | SPR (0.75) | SPRALKMAP3K7IRAK4IRAK1 | |
| SCHEMBL10270581 | 0.88 | SPR (0.75) | SPRALKMAP3K7IRAK4IRAK1 | |
| Hydrochloric Acid SCHEMBL572499 | 0.84 | SPR (0.77) | SPRALKIRAK1MET | |
| Hydrochloric Acid SCHEMBL572500 | 0.84 | SPR (0.77) | SPRALKIRAK1MET | |
| SCHEMBL20985265 | 0.81 | MAP3K7 (0.83) | SPRALKMAP3K7IRAK4IRAK1 | |
| SCHEMBL20985268 | 0.81 | MAP3K7 (0.83) | SPRALKMAP3K7IRAK4IRAK1 | |
| SCHEMBL571741 | 0.81 | SPR (0.57) | SPRALKIRAK4METEGFR | |
| SCHEMBL14971480 | 0.79 | ALK (0.80) | SPRALKMAP3K7IRAK4IRAK1 | |
| SCHEMBL10270813 | 0.79 | MAP3K7 (0.74) | SPRALKMAP3K7IRAK4IRAK1 | |
| SCHEMBL15200278 | 0.78 | ALK (0.81) | SPRALKMAP3K7IRAK4IRAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2611784-A1 | BENZIMIDAZOLE AND AZABENZIMIDAZOLE COMPOUNDS THAT INHIBIT ANAPLASTIC LYMPHOMA KINASE | Amgen, Inc (US) | 2013-07-10 | — | — | EP | disclosed |
| WO-2012018668-A1 | BENZIMIDAZOLE AND AZABENZIMIDAZOLE COMPOUNDS THAT INHIBIT ANAPLASTIC LYMPHOMA KINASE | AMGEN INC. (US) | 2012-02-09 | — | — | WO | disclosed |